Diagnosis of Diabetes Using HbA1c
Diabetes can be definitively diagnosed with an HbA1c value of ≥6.5% (≥48 mmol/mol) when measured using a standardized, NGSP-certified laboratory method. 1
Diagnostic Criteria for Diabetes
The American Diabetes Association (ADA) has established the following diagnostic criteria for diabetes:
- HbA1c ≥6.5% (≥48 mmol/mol) using a method that is NGSP certified and standardized to the DCCT assay 1
- Fasting plasma glucose (FPG) ≥126 mg/dL (7.0 mmol/L) after at least 8 hours of fasting 1
- 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test (OGTT) 1
- Random plasma glucose ≥200 mg/dL (11.1 mmol/L) in patients with classic symptoms of hyperglycemia or hyperglycemic crisis 1
Confirmation Requirements
Unless there is a clear clinical diagnosis (e.g., patient with hyperglycemic crisis or classic symptoms with random glucose ≥200 mg/dL), a second test is required for confirmation 1:
- Ideally, the same test should be repeated for confirmation
- If two different tests (e.g., HbA1c and FPG) are both above diagnostic thresholds, this also confirms the diagnosis
- When results are discordant, the test that is above the diagnostic threshold should be repeated
Advantages of Using HbA1c for Diagnosis
- Greater convenience (no fasting required)
- Better preanalytical stability
- Less day-to-day perturbations during periods of stress and illness 1
- Reflects average glycemia over the preceding 60-90 days 1
Limitations and Precautions
HbA1c testing should not be used for diagnosis in the following situations:
- Conditions with abnormal red blood cell turnover:
- Pregnancy (second and third trimesters)
- Hemolytic anemia
- Recent blood loss or transfusion
- Hemodialysis
- Erythropoietin therapy 1
- Hemoglobinopathies (use assays without interference or use glucose criteria instead)
- Marked discordance between measured A1C and plasma glucose levels 1
Prediabetes Classification
Individuals with HbA1c levels between 5.7% and 6.4% (39-46 mmol/mol) are classified as having prediabetes 1, 2:
- HbA1c 5.7-6.0%: 3-8 fold increased risk of developing diabetes 2
- HbA1c 6.0-6.4%: approximately 20 times higher risk of developing diabetes 2
Testing Considerations
- Only NGSP-certified methods should be used for diagnosis 1
- Point-of-care HbA1c testing should not be used for diagnosis unless using FDA-approved devices at CLIA-certified laboratories that perform testing of moderate complexity or higher 1
- Laboratory standardization is critical for accurate diagnosis 1
Clinical Pearls
- The HbA1c cut-off of 6.5% has high specificity but lower sensitivity compared to glucose-based criteria 3
- When using HbA1c for diagnosis, approximately one-third fewer cases of undiagnosed diabetes are identified compared to using fasting glucose criteria 1
- However, the greater convenience of HbA1c testing may lead to wider application and potentially increase the overall number of diagnoses 1
- Marked discrepancies between measured HbA1c and plasma glucose levels should prompt consideration that the HbA1c assay may not be reliable for that individual 1
By understanding these diagnostic criteria and their limitations, clinicians can appropriately diagnose diabetes using HbA1c while recognizing situations where glucose-based testing may be more appropriate.